OCA at 09:08, 30 August 2023

OCA — Wed, 30 Aug 2023 09:08:49 GMT

←Older revision		Revision as of 09:08, 30 August 2023
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 8evw is ~~ON HOLD until Paper~~ Publication	+	==DdlA from Pseudomonas aeruginosa PAO1 in complex with ATP and D-ala-D-ala==
		+	<StructureSection load='8evw' size='340' side='right'caption='[[8evw]], [[Resolution\|resolution]] 1.22Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[8evw]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Pseudomonas_aeruginosa_PAO1 Pseudomonas aeruginosa PAO1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8EVW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8EVW FirstGlance]. <br>
		+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.22Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene>, <scene name='pdbligand=DAL:D-ALANINE'>DAL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8evw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8evw OCA], [https://pdbe.org/8evw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8evw RCSB], [https://www.ebi.ac.uk/pdbsum/8evw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8evw ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/DDLA_PSEAE DDLA_PSEAE] Cell wall formation.[HAMAP-Rule:MF_00047]
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Pseudomonas aeruginosa is a major human pathogen in the healthcare setting. The emergence of multi-drug-resistant and extensive drug-resistant P. aeruginosa is of great concern, and clearly indicates that new alternatives to current first-line antibiotics are required in the future. Inhibition of d-alanine-d-alanine production presents as a promising avenue as it is a key component in the essential process of cell wall biosynthesis. In P. aeruginosa, d-alanine-d-alanine production is facilitated by two isoforms, d-alanine-d-alanine ligase A (PaDdlA) and d-alanine-d-alanine ligase B (PaDdlA), but neither enzyme has been individually characterised to date. Here, we present the functional and structural characterisation of PaDdlA and PaDdlB, and assess their potential as antibiotic targets. This was achieved using a combination of in vitro enzyme-activity assays and X-ray crystallography. The former revealed that both isoforms effectively catalyse d-alanine-d-alanine production with near identical efficiency, and that this is effectively disrupted by the model d-alanine-d-alanine ligase inhibitor, d-cycloserine. Next, each isoform was co-crystallised with ATP and either d-alanine-d-alanine or d-cycloserine, allowing direct comparison of the key structural features. Both isoforms possess the same structural architecture and share a high level of conservation within the active site. Although residues forming the d-alanine pocket are completely conserved, the ATP-binding pocket possesses several amino acid substitutions resulting in a differing chemical environment around the ATP adenine base. Together, these findings support that the discovery of dual PaDdlA/PaDdlB competitive inhibitors is a viable approach for developing new antibiotics against P. aeruginosa.

-	~~Authors~~:	+	Comparative functional and structural analysis of Pseudomonas aeruginosa d-alanine-d-alanine ligase isoforms as prospective antibiotic targets.,Pederick JL, Woolman JC, Bruning JB FEBS J. 2023 Aug 15. doi: 10.1111/febs.16932. PMID:37581574<ref>PMID:37581574</ref>

-	~~Description~~:	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased~~ Structures]]	+	</div>
		+	<div class="pdbe-citations 8evw" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Pseudomonas aeruginosa PAO1]]
		+	[[Category: Bruning JB]]
		+	[[Category: Pederick JL]]
		+	[[Category: Woolman JC]]

OCA at 05:04, 9 November 2022

OCA — Wed, 09 Nov 2022 05:04:01 GMT

←Older revision		Revision as of 05:04, 9 November 2022
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 8evw is ON HOLD	+	The entry 8evw is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "8evw" [edit=sysop:move=sysop]

OCA — Wed, 26 Oct 2022 04:07:58 GMT

Protected "8evw" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:07, 26 October 2022

OCA: New page: '''Unreleased structure''' The entry 8evw is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Wed, 26 Oct 2022 04:07:57 GMT

New page: '''Unreleased structure''' The entry 8evw is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 8evw is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

8evw - Revision history

OCA at 09:08, 30 August 2023

OCA at 05:04, 9 November 2022

OCA: Protected "8evw" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8evw is ON HOLD Authors: Description: Category: Unreleased Structures